[13 May 2013]
Products Affected - Description
Typhim Vi Injection, Sanofi Pasteur
25 mcg/0.5 mL, 0.5 mL prefilled syringe (NDC 49281-0790-51)
Reason for the Shortage
- Sanofi Pasteur voluntarily recalled 5 lots of Typhim Vi prefilled syringes and 1 lot of multidose vials in September 2012 due to a concern that these lots may contain lower antigen content.
- The live, oral typhoid vaccine (Vivotif capsule) is not affected by this shortage. According to CDC, the live, oral typhoid vaccine can be used as an alternative to Typhim Vi injectable vaccine in patients 6 years and older who do not have contraindications to a live vaccine.
Available Products
Typhim Vi Injection, Sanofi Pasteur
25 mcg/0.5 mL, 10 mL multidose vial (NDC 49281-0790-20)
Estimated Resupply Dates
- Sanofi Pasteur has Typhim Vi prefilled syringes on back order and the company estimates a release date in July 2013.
Related Shortages
Updated
May 13, 2013; March 6, 2013; January 25, 2013; November 6, 2012 University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins